Search

everythinglearnresearchcommunity

for

Search:↓

Taking low-dose spironolactone and metformin together works better for PCOS symptoms than either drug alone.

Obese Hispanic women with PCOS are at higher risk for metabolic problems than non-Hispanic white women.

PCOS women with COVID-19 have higher cardiometabolic risks.

Doctors need to be better prepared to assess and treat obesity in patients.

Women with excessive body hair often have higher male hormones and related health issues.

The conclusion is that obesity should be managed with a slow, balanced approach to diet and exercise, with medication and surgery as additional options, and education and access to care are important.

The conclusions are: fecal short-chain fatty acids may help prevent cancer, fiber intake can reduce obesity, weight loss is hard for obese people, low BMI cancer patients are more prone to chemotherapy side effects, intermittent fasting benefits gut health, cherry laurel has health benefits in rats, certain gene variations can increase stress in hair loss patients, fecal acids can affect blood sugar levels, cold agglutinin can affect blood test results in autoimmune patients, and people with Crohn's disease have higher levels of a certain chemical in their blood.

Hair loss in middle-aged women is often linked to insulin resistance and a family history of hair loss, particularly from their fathers.

Vitamin D deficiency is linked to a higher chance of metabolic syndrome in women with PCOS.

Metabolic syndrome is common in African populations, needing urgent prevention and treatment.

Testosterone and dihydrotestosterone have similar effects on body composition and metabolic health in men.

Metabolic Syndrome is linked to several skin conditions, and stem cell therapy might help treat them.

Obese women with PCOS are more likely to have fatty liver disease.

A combined drug and laser treatment improved hirsutism in a PCOS patient, also enhancing her heart health and requiring regular liver and kidney checks.

Women with PCOS have similar bone density to healthy women, but those who are obese have higher bone density at some body sites.

Hair loss in women linked to higher sexual dysfunction risk.

Women with PCOS have a higher risk of metabolic syndrome and need lifestyle changes and treatment.

Obesity is linked to various skin disorders, which can help with early diagnosis and prevention of long-term health issues.

Osteoporotic postmenopausal Sudanese women have a high risk of cardiovascular disease.

Early hair loss in men and women may indicate a higher risk of heart disease and metabolic problems.

Hormone therapy for trans individuals is effective and generally safe in the short term.

Women with PCOS and higher androgen levels are more likely to have fatty liver disease.

Metformin improves hair growth and menstrual frequency in women with PCOS and hirsutism.

Women with PCOS have higher xanthine oxidase activity linked to inflammation and heart disease risks.

The document suggests that there might be an autoimmune link between polycystic ovary syndrome and Graves' disease.

Men's age, urinary symptoms, and heart health risks create different types of erectile dysfunction.

Policemen have more hair loss due to obesity, sunlight exposure, and stress.

Normal-range ALT levels can indicate metabolic and hormonal imbalances in young women.

SGLT2 inhibitors may help manage PCOS symptoms effectively.

Obese and lean women with PCOS have different symptoms and need different treatments.